Comparative Study on Immunogenidty of Recombinant BCG Vs BCG

刘海涛,夏术阶,孙晓文,韩邦昊,阮渊,卓见
DOI: https://doi.org/10.3760/ema.j.issn.1001-0030.2009.03.030
2009-01-01
Abstract:Objective To compare the immunogenicity of recombinant BCG (rBCG) secreting interleukin-2 (IL-2) and BCG, and investigate the mechanism of immunotherapeutic effect on BALB/c Mice.Methods Mimieing the standard BCG instillation schedule, BALB/c mice were inoculated intrave-nously through the lateral tail vein 5 x 105 colony forming units (CFU) of rBCG stmin comparing with 1 x106 CFU of BCG and PBS weekly for 6 weeks.MTr assay was used to confirm the effect of rBCG on indue-tion of macrophage activity and proliferation of T lymphocyte.The changes of CD4+ and CD8 + subsets were examined by flow eytometry.Thl cytokines (IL-2 and IFN-γ) and Th2 cytokine (IL-4) in the cul-ture supematant of mice spleen lymphocytes were detected by an enzyme-linked immunosorbent assay (ELBA) after 2,4 and 6 successive weekly BCG instillations.Results During 6 weekly BCG strain and rBCG inoculation a time-dependent induction of the T lymphocyte proliferation, CD subsets, macrophage activity and cytokines (including IL-2, IL-4 and IFN-γ) was observed.At the different time points, there was significant difference between the rBCG therapy group and BCG therapy group or control group.Con-clusion Recombinant BCG strain enhanced immunostimulatory potential in BALB/c mice and could ef-fectively induce specific stronger immune response in BALB/c mice than BCG did.This immune reaction induced by rBCG was CD4+ T eell-depent and defined as a major Thl accompanied by a minor Th2 re-sponse.
What problem does this paper attempt to address?